1. Home
  2. LMNR vs IMRX Comparison

LMNR vs IMRX Comparison

Compare LMNR & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Limoneira Co

LMNR

Limoneira Co

HOLD

Current Price

$13.07

Market Cap

235.0M

ML Signal

HOLD

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$4.41

Market Cap

265.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMNR
IMRX
Founded
1893
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
235.0M
265.3M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
LMNR
IMRX
Price
$13.07
$4.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$20.00
$17.20
AVG Volume (30 Days)
122.5K
2.4M
Earning Date
06-08-2026
05-04-2026
Dividend Yield
2.37%
N/A
EPS Growth
N/A
37.75
EPS
N/A
N/A
Revenue
$159,723,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$13.95
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.67
$2.29
52 Week High
$16.99
$10.08

Technical Indicators

Market Signals
Indicator
LMNR
IMRX
Relative Strength Index (RSI) 55.00 45.84
Support Level $12.42 $3.95
Resistance Level $13.69 $5.36
Average True Range (ATR) 0.61 0.37
MACD 0.07 0.02
Stochastic Oscillator 76.36 30.23

Price Performance

Historical Comparison
LMNR
IMRX

About LMNR Limoneira Co

Limoneira Co is predominantly an agribusiness company. Its current operations consist of fruit production and marketing, rental operations, real estate, and capital investment activities. The company has three business divisions; agribusiness, rental operations, and real estate development. The agribusiness division which accounts for a majority of the firm's revenue represents its core operations of farming, harvesting, lemon packing, and lemon sales operations. The company's reportable operating segments are fresh lemons, lemon packing, avocados, and other agribusiness, which predominantly includes oranges, specialty citrus, other crops, and farm management services. A majority of its revenue is derived from the Fresh Lemons segment.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: